New Study by Predicine Published in The New England Journal of Medicine Highlights the Clinical Benefits of MRD Liquid Biopsy Assay in Genentech’s Phase 1 Clinical Trial
Predicine Announces New Study Published in The New England Journal of Medicine Demonstrating Clinical Utility Background PredicineBEACON™ and PredicineWES+™ were utilized in a recent study to identify and track a wide range of genomic alterations and emerging resistance mechanisms in patients with advanced or metastatic solid tumors. This groundbreaking research offers valuable insights into the…